Recent studies have demonstrated that the TFPI-2, a Kunitz-type proteinase inhibitor, could inhibit cell migration, proliferation, and promote cell apoptosis in glioma cells24–26. This evidence concerns the gene TFPI2 and central nervous system cancer.